Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema.

[1]  T. Williams.  DX-88, a novel recombinant protein inhibitor of plasma kallikrein: Safety and immunogenicity in early studies , 2005 .

[2]  Anthony Williams,et al.  DX-88 and HAE: a developmental perspective. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.